ABCELLERA BIOLOGICS INC (ABCL)

CA00288U1066 - Common Stock

3.89  -0.08 (-2.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
38.02M485.40M375.20M233.20M11.60M
Operating Expenses
275.23M268.90M170.80M77.10M15.70M
Research and Development
175.66M107.90M62.10M29.40M10.10M
Selling, General, and Administrative Expenses
75.18M66.80M48.80M15.80M4.00M
Operating Income
-237.21M216.50M204.40M156.00M-4.10M
Interest Income/Expense
46.15M12.00M-2.80M-2.80M100.00K
Other Income/Expense
17.03M10.60M17.50M8.30M1.80M
Non Recurring Items
N/AN/AN/A-3.70MN/A
Income Before Taxes
-174.03M239.10M219.10M157.80M-2.20M
Income Tax
-27.63M80.60M65.70M38.90MN/A
Net Income
-146.40M158.50M153.50M118.90M-2.20M
EBITDA
-212.81M244.40M218.90M160.80M-2.50M
 
Per Share Data
EPS Diluted Total Ops
-0.510.500.480.44-0.01
Non GAAP EPS
-0.520.500.47N/AN/A
 
Statistics
Profit Margin
-385.00%32.65%40.91%50.99%-18.97%
Operating Profit Margin
-623.82%44.60%54.48%66.90%-35.34%

All data in USD

Charts